1Jeng LB,Changlai SP,Shen YY,et al.Limited value of ^18F-2-deoxyglucose positron emission tomography to detect hepatocellular carcinoma in hepatitis B virus carriers[J].Hepatogastrconterology,2003,50(54):2154 -2156.
2Lee JD,Yun M,Lee JM,et al.Analysis of gene expression profiles of hepatocellular carcinomas with regard to ^^18F-fluorodeoxyglucose uptake pattern on positron emission tomography[J].Eur J Nucl Med Mol Imaging,2004,31(12):1621 -1630.
4Hatano E,Ikai 1,Higashi T,et al.Preoperative positron emission tomography with fluorine-18-fluorodeoxyglucose is predictive of prognosis in patients with hepatocellular carcinoma after resection[J].World J Surg,2006,30(9):1736-1741.
5Shiomi S,Nishiguchi S,Ishizu H,et al.Usefulness of positron emission tomography with ^18F-fluorodeoxyglucose for predicting outcome in patients with hepatocellular carcinoma[J].Am J Gastroenterol,2001,96(6):1877-1880.
6Bohm B,Voth M,Geoghegan J,et al.Impact of positron emission tomography on strategy in liver resecton for primary and secondary liver tumors[J].J Cancer Res Clin Oncol,2004,130(5):266 -272.
9Wudel,Jr,Delbeke D.The role of[^18F]fluorodeoxyglucose positron emission tomography imaging in the evaluation of hepatocellular carcinoma[J].Am Surg,2003,69(2):117 -126.
10Sugiyama M,Sakahara H,Torizuka T,et al.^18F-FDG PET inthe detection of extrahepatic metastases from hepatocellular carcinoma[J].J Gastroenterol,2004,39(10):961 -968.
4Patz EF,Lowe VJ,HoffmanJM,et al.Focal pulmonary abnormalities:evaluation with 18F-fluorodexy glucose PET scanning [J].Radiology,1993,188(45):487-90.
5Sazon DA,Santiago SM,Soohoo GW,et al.Fluowdexyglucose positron emission tomography in the detection and staging lung cancer[J].AmJRespir Crit Care Med,1996,153(1):417-21.
6Adler LP,CroweJP,Kaisi AL,et al.Evaluation of breast mass and axillary lymph nodes with FDG-PET[J].Radiology,1987,148(54):365-77.
7Okazumi S,Isono K,Enimoto K,et al.Evaluation of liver tumors using 18F-FDG PET characterization of tumor and assessment of effect oftreatment[J].JNucl Med,1992,33(9):333-9.
8Magrath I,LitvakJ.Cancer in developing countries:opportunity and challenge[J].JNatl Cancer Inst,1993,85(17):862-73.
9Higashi K,Veda Y,Yagishita M,et al.FDG PET measurement of proliferative potiential of non-small cell lung cancer [J].JNucl Med,2000,41(1):85-92.
10Hawkins RA,Hohc H,GlaspyJ,et al.The role of positron emission tomography in oncology and other whole body application [J].Semin Nucl Med,1992,22(8):268-9.
